TruAlt Bioenergy quarterly results

Q2 FY27 · Jul–Sep 2026
₹ croreQ2 FY27Q2 FY26Change
Revenue811115+606.2%
EBITDA101−4.5—
EBITDA margin12.5%−4.0%+16.4 pts
Profit before tax47.1−49.2—
Net profit35.0−37.9—
EPS₹4.04−₹5.37—

Every quarter

₹ crore except per share
Tap a line for its trendQ2 FY27Sep 2026Q1 FY27Jun 2026Q4 FY26Mar 2026Q3 FY26Dec 2025Q2 FY26Sep 2025Q1 FY26Jun 2025
811627596713115304
12.614.531.417.614.822.7
824641627731130327
Expenses
22933447142389.373.5
27510.653.71203.622.5
11247.7−216−49.4−0.7124
12.112.113.512.510.711.2
42.544.043.540.138.637.8
24.224.822.921.820.820.7
81.690.315573.016.531.4
777563543641179321
101133119134−4.541.5
76.910895.8112−25.320.8
Profit
47.178.483.789.7−49.25.8
47.178.483.789.7−49.25.8
0.60.90.50.71.30.0
11.518.322.219.8−12.51.1
12.119.222.820.5−11.21.1
35.059.360.969.2−37.94.7
35.059.360.969.2−37.94.7
−0.10.00.10.00.10.0
34.959.361.069.2−37.94.7
34.757.259.969.3−37.94.7
0.32.11.1−0.10.00.0
Per share
₹4.04₹6.67₹6.99₹8.07−₹5.37₹0.67
₹4.04₹6.67₹6.99₹8.07−₹5.37₹0.67
Other comprehensive income — detail
−0.10.00.10.00.10.0
−0.10.00.10.10.10.0
−0.00.00.00.00.00.0
34.757.260.069.4−37.94.7
0.32.11.1−0.10.00.0
Per share — as-filed variants
₹4.04₹6.67₹6.99₹8.07−₹5.37₹0.67
₹4.04₹6.67₹6.99₹8.07−₹5.37₹0.67
Derived — gross profit (revenue − materials − purchases − Δ inventories)
19523528721922.684.1
24.0%37.5%48.2%30.8%19.7%27.7%
Adjusted (ex-exceptional items) — derived
47.178.483.789.7−49.25.8
35.059.360.969.2−37.94.7
₹4.04₹6.67₹6.99₹8.07−₹5.37₹0.67
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

TRUALT₹375.10

TruAlt Bioenergy Limited

· FMCG & Retail
AnnualQuarterly₹ CrorePeersSANSTARAEROPLANEGRMOVERCLSELAVTNPLGULPOLYBSHSLREGAALMcap ₹3,217 Cr
View
In ₹ Crore except Per Share
3 Months Ending
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Revenue from Operations303.9114.9713.2595.5626.9811.1
Other Income22.714.817.631.414.512.6
Total Income326.6129.6730.9626.9641.4823.7
Expenses
+ Cost of Materials Consumed73.589.3423.3471.3333.5228.6
+ Purchases of Stock-in-Trade22.53.6119.953.710.6275.3
+ Changes in Inventories123.7-0.7-49.4-216.347.7112.4
+ Employee Benefit Expense11.210.712.513.512.112.1
+ Finance Costs37.838.640.143.544.042.5
+ Depreciation & Amortisation20.720.821.822.924.824.2
+ Other Expenses31.416.573.0154.590.381.6
Total Expenses320.8178.8641.2543.2563.0776.6
EBITDA41.5-4.5134.0118.8132.8101.2
EBIT20.8-25.3112.295.8108.076.9
Profit
PBT before Exceptional Items5.8-49.289.783.778.447.1
Pretax Income5.8-49.289.783.778.447.1
+ Current Tax0.01.30.70.50.90.6
+ Deferred Tax1.1-12.519.822.218.311.5
Tax Expense1.1-11.220.522.819.212.1
Net Income4.7-37.969.260.959.335.0
+ Net Income — Continuing Ops4.7-37.969.260.959.335.0
+ Other Comprehensive Income0.00.10.00.10.0-0.1
Total Comprehensive Income4.7-37.969.261.059.334.9
Net Income to Common4.7-37.969.359.957.234.7
Minority Interest0.00.0-0.11.12.10.3
Per Share
Basic EPS0.67-5.378.076.996.674.04
Diluted EPS0.67-5.378.076.996.674.04
Other Comprehensive Income — detail
+ Other Comprehensive Income0.00.10.00.10.0-0.1
+ Items NOT to be Reclassified to P&L0.00.10.10.10.0-0.1
+ Tax on Items NOT to be Reclassified0.00.00.00.00.0-0.0
Comprehensive Income — Owners of Parent4.7-37.969.460.057.234.7
Comprehensive Income — Non-controlling Interests0.00.0-0.11.12.10.3
Per Share — as-filed variants
Basic EPS — Continuing Operations0.67-5.378.076.996.674.04
Diluted EPS — Continuing Operations0.67-5.378.076.996.674.04
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit84.122.6219.5286.8235.1194.8
Gross Margin %27.6919.7230.7748.1637.5024.02
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)5.8-49.289.783.778.447.1
Net Income Adj (tax-effected)4.7-37.969.260.959.335.0
EPS Adj0.67-5.378.076.996.674.04
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.0010.00
Filed Debt Equity1.38—0.72———
Filed Dscr0.91—1.05———
Filed Iscr1.94—2.20———
Paid Up Equity Capital70.685.885.885.885.885.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

TruAlt Bioenergy Q2 FY27 results (July–September 2026)

Filed with NSE on Friday, 23 October 2026 at 7:48 pm IST

TruAlt Bioenergy (NSE: TRUALT) reported its Q2 FY27 results (July–September 2026) on Friday, 23 October 2026 at 7:48 pm IST. Consolidated net profit was ₹34.7 crore, against a loss of ₹37.9 crore in Q2 FY26 and down 39.3% from ₹57.2 crore in Q1 FY27. Revenue from operations was ₹811 crore, up 606.2% year on year and up 29.4% from the previous quarter.

Q2 FY26 results (a year earlier)
11 November 2025
Q3 FY27 results due by
14 February 2027

Q2 FY27 at a glance · consolidated

Net profit
₹34.7 Crloss ₹37.9 Cr in Q2 FY26−39.3% vs Q1 FY27
Revenue from operations
₹811 Cr+606.2% vs Q2 FY26+29.4% vs Q1 FY27
Operating margin (EBIT)
9.5%+31.5 pts vs Q2 FY26−7.7 pts vs Q1 FY27EBIT ₹76.9 Cr
EBITDA
₹101 Cr−₹4.5 Cr in Q2 FY26−23.8% vs Q1 FY27margin 12.5%
Earnings per share (basic)
₹4.04−39.4% vs Q1 FY27
Net profit margin
4.3%+37.2 pts vs Q2 FY26−4.8 pts vs Q1 FY27

Questions

What was TruAlt Bioenergy's net profit in Q2 FY27?

Consolidated net profit was ₹34.7 crore, against a loss of ₹37.9 crore in Q2 FY26 and down 39.3% from ₹57.2 crore in Q1 FY27.

What was TruAlt Bioenergy's revenue in Q2 FY27?

Revenue from operations was ₹811 crore, up 606.2% year on year and up 29.4% from the previous quarter.

What is TruAlt Bioenergy's net profit margin?

TruAlt Bioenergy's net profit margin was 4.3% in Q2 FY27 (net profit as a share of revenue from operations), against −33.0% in Q2 FY26 (up 37.2 percentage points). For FY26 as a whole it was 5.6%.

How were TruAlt Bioenergy's Q2 FY27 results?

A net profit of ₹34.7 crore, against a loss of ₹37.9 crore in Q2 FY26. Revenue was up 606.2% at ₹811 crore. The operating margin was 9.5%, up 31.5 percentage points from −22.1% a year earlier. Against Q1 FY27, net profit was down 39.3% and revenue up 29.4%.

What was TruAlt Bioenergy's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹76.9 crore, a margin of 9.5%, against 17.2% in Q1 FY27 and −22.1% in Q2 FY26. EBITDA was ₹101 crore, 12.5% of revenue.

What was TruAlt Bioenergy's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹91.8 crore, against a loss of ₹33.1 crore in the same months a year earlier. Revenue from operations was ₹1,438 crore, up 243.4%.

What was TruAlt Bioenergy's EPS in Q2 FY27?

Basic earnings per share were ₹4.04.

What was TruAlt Bioenergy's net profit in FY26?

Consolidated net profit was ₹95.9 crore in FY26 (April 2025–March 2026).

What was TruAlt Bioenergy's revenue in FY26?

Revenue from operations was ₹1,728 crore in FY26 (April 2025–March 2026).

How has TruAlt Bioenergy's profit changed over the last four quarters?

Net profit by quarter: ₹69.3 crore in Q3 FY26, ₹59.9 crore in Q4 FY26, ₹57.2 crore in Q1 FY27 and ₹34.7 crore in Q2 FY27. That is ₹221 crore over the four quarters. Revenue from operations: ₹713 crore, ₹596 crore, ₹627 crore and ₹811 crore.

When did TruAlt Bioenergy announce its Q2 FY27 results?

On Friday, 23 October 2026 at 7:48 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 11 November 2025.

When will TruAlt Bioenergy announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these TruAlt Bioenergy figures come from?

From TruAlt Bioenergy's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 23 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.